L-Aspartic acid β-hydroxamate
CAS : 1955-68-6
Ref. 3D-BAA95568
| 1g | Arrêté | ||
| 25mg | Arrêté | ||
| 50mg | Arrêté | ||
| 100mg | Arrêté | ||
| 250mg | Arrêté | ||
| 500mg | Arrêté |
Informations sur le produit
Nom :
L-Aspartic acid β-hydroxamate
Description :
L-Aspartic acid β-hydroxamate is a chemical compound that has been shown to inhibit angiogenesis in the eye. It prevents the growth of new blood vessels by inhibiting vascular endothelial growth factor (VEGF) activity. L-Aspartic acid β-hydroxamate also inhibits racemase and aminopeptidase activities, which may be important for its anti-cancer effects. L-Aspartic acid β-hydroxamate has been shown to have antineoplastic properties in cultured cells and animal models, with an inhibition constant (Ki) of ˜1 μM for the enzyme racemase. It also inhibits transfer reactions, which are important for DNA synthesis and protein synthesis.
Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :
Propriétés chimiques
Masse moléculaire :
148.12 g/mol
Formule :
C4H8N2O4
Degré de pureté :
Min. 95%
MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :
